Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Aldosterone in acromegaly.

P Marks, R Vincent, B Wilson

    The American Journal of the Medical Sciences
    |May 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    In acromegaly patients, high prolactin levels correlated with elevated aldosterone metabolism and hypertension. Bromocryptine treatment lowered both prolactin and blood pressure, suggesting a link between these factors.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Long-term functional success and patient-reported outcomes after female one-stage buccal mucosal graft urethroplasty.

    Actas urologicas espanolas·2024
    Same author

    Achievement of Target Gain Larger than Unity in an Inertial Fusion Experiment.

    Physical review letters·2024
    Same author

    Incidence and risk factors of heat-related illness in dogs from New South Wales, Australia (1997-2017).

    Australian veterinary journal·2023
    Same author

    Mortality and mental health funding-do the dollars add up? Eating disorder research funding in Australia from 2009 to 2021: a portfolio analysis.

    The Lancet regional health. Western Pacific·2023
    Same author

    Effects of heat stress on markers of skeletal muscle proteolysis in dairy cattle.

    Journal of dairy science·2023
    Same author

    Standardized 100% single rooms in new hospital builds: a high-cost strategy with low use of showers.

    The Journal of hospital infection·2023
    Same journal

    Providers' Perspectives on Hospital-Based Tobacco Treatment Efforts.

    The American journal of the medical sciences·2026
    Same journal

    In Memoriam: Maurice A. Mufson, MD, MACP.

    The American journal of the medical sciences·2026
    Same journal

    Outcomes of Acute Myeloid Leukemia Patients Admitted to the Intensive Care Unit within 100 days of Allogeneic Hematopoietic Stem Cell Transplantation.

    The American journal of the medical sciences·2026
    Same journal

    Association Between Reverse Triiodothyronine and Cardiac Complications in Patients with Uncontrolled Graves' Disease.

    The American journal of the medical sciences·2026
    Same journal

    Chlorthalidone vs. hydrochlorothiazide in hypertension management: Lessons for guiding clinical practice.

    The American journal of the medical sciences·2026
    Same journal

    The impact of COVID-19 on alcohol-associated hepatitis and alcohol-associated cirrhosis.

    The American journal of the medical sciences·2026
    See all related articles

    Area of Science:

    • Endocrinology
    • Nephrology

    Background:

    • Acromegaly is a condition characterized by excessive growth hormone production.
    • Hypertension is a common comorbidity in patients with acromegaly.
    • The role of aldosterone metabolism in acromegaly-associated hypertension requires further investigation.

    Purpose of the Study:

    • To investigate the relationship between aldosterone metabolism and hypertension in patients with acromegaly.
    • To explore the potential impact of prolactin levels on aldosterone metabolism and blood pressure in acromegaly.

    Main Methods:

    • Studied ten patients with acromegaly (six active, four inactive).
    • Measured tetrahydroaldosterone-3-glucuronide and prolactin levels.
    • Monitored blood pressure before and after bromocryptine administration.

    Related Experiment Videos

    Main Results:

    • Tetrahydroaldosterone-3-glucuronide levels were highest in patients with the highest prolactin levels.
    • Hypertension was present in patients with elevated prolactin and tetrahydroaldosterone-3-glucuronide.
    • Bromocryptine treatment led to reduced prolactin, tetrahydroaldosterone-3-glucuronide, and blood pressure.

    Conclusions:

    • Elevated prolactin levels may influence aldosterone metabolism in acromegaly.
    • These metabolic changes might contribute to hypertension in active acromegaly.
    • Bromocryptine therapy shows potential in managing both hormonal imbalances and hypertension in acromegaly.